Original Research

To Compare the Frequency of Adverse Outcomes of Severe Versus Mild Oligohydramnios at Full Term

DOI https://doi.org/10.70302/jpsim.v3i4.2265
Received: 26 Jul 2022 Accepted: 28 Sep 2022 Published Online: 18 Dec 2022

Abstract

Objective

Oligohydramnios is a disorder that occurs in pregnancy and is characterized by an amniotic fluid deficiency. To determine the frequency of severe oligohydramnios in pregnant females at term presenting diagnosis of oligohydramnios and to compare the frequency of adverse outcomes of severe versus mild oligohydramnios at term.

Methods

The Descriptive case series was held in Department of Obstetrics and Gynecology, CMH, Okara for 06 months i.e. from 28-12-2019 to 29-6-2020. Keeping in view the inclusion criteria, 100 pregnant females were enrolled. Then females underwent ultrasound and level of AFI was noted. If AFI<5cm, then severe oligohydramnios were labeled and females were divided in two groups i.e. mild oligohydramnios and severe oligohydramnios. Females were followed up till delivery and adverse outcomes were noted.

Results

The mean age group of females was 27.39±3.4 years. The severe oligohydramnios was found in 50 (50%) patients. When were compare the adverse outcome with oligohydramnios we found that the C-section [mild oligohydramnios =26 (52%) & in severe oligohydramnios =33(66%) females], perinatal death [mild oligohydramnios =3(6%) & in severe oligohydramnios =6(12%) females], low Apgar score in [mild oligohydramnios =26(52%) & in severe oligohydramnios=33(66%) females], similarly the low birth weight [mild oligohydramnios =1(2%) & in severe oligohydramnios=2(4%) females]. The adverse outcome showed statistically insignificant difference i.e. p-value>0.05.

Conclusion

About half oligohydramnios patients had severe oligohydramnios, while there is no significant association of mild or severe oligohydramnios with adverse feto-maternal outcome.

Keywords
Oligohydramnios Adverse Outcome Mild Severe amniotic fluid index

How to Cite This Article

Zafar A, Shauket K, Fatima N, Abbas S, Nawaz M, Shahbaz S. To Compare the Frequency of Adverse Outcomes of Severe Versus Mild Oligohydramnios at Full Term. J Pak Soc Intern Med. 2022;3(4):331–335. doi:10.70302/jpsim.v3i4.2265

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Amniotic fluid. Williams Obstetrics. 24th ed. New York: Mcgraw-hill; 2014: p. 460-76.
  2. Souza ASR, Andrade LRd, Silva FLTd, Cavalcanti AN, Guerra GVdQL. Maternal and perinatal outcomes in women with decreased amniotic fluid. Revi Brasi Ginecol Obstet. 2013;35(8):342-8.
  3. Choi SR. Borderline amniotic fluid index and perinatal outcomes in the uncomplicated term pregnancy. J Mater-Fetal Neonat Med. 2016;29(3):457-60.
  4. Rathod S, Samal SK. Evaluation of Maternal and Perinatal Outcomes of Induction in Borderline Oligohydramnios at Term. J Clin Diag Res. 2017;11(9):QC05.
  5. Hashimoto K, Kasdaglis T, Jain S, Atkins K, Harman CR, Baschat AA. Isolated low-normal amniotic fluid volume in the early third trimester: association with adverse perinatal outcomesa. J Peri Med. 2013;41(4):349-53.
  6. Subash K, Poudel R, Khadka S, Shrestha A. Prevalence of Congenital Anomalies in Oligohydramnios: A Hospital Based Study in Western Nepal. Nepal J Radiol. 2019;9(1):7-11.
  7. abclawcenters. Oligohydramnios (Low Amniotic Fluid). [updated 2020,cited 2022]; Available from: [https://www.abclawcenters.com/practice-areas/prenatal-birth-injuries/maternal-medical-conditions/oligohydramnios/]
  8. Chauhan SP, Hendrix NW, Morrison JC, Magann EF, Devoe LD. Intrapartum oligohydramnios does not predict adverse peripartum outcome among high-risk parturients. Am J Obstet Gynecol. 1997;176(6):1130-8.
  9. Zhang J, Troendle J, Meikle S, Klebanoff MA, Rayburn WF. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG: Int J Obstet Gynaecol. 2004;111(3):220-5.
  10. Magann EF, Nolan TE, Hess LW, Martin RW, Whitworth NS, Morrison JC. Measurement of amniotic fluid volume: accuracy of ultrasonography techniques. Am J Obstet Gynecol. 1992;167(6):1533-7.
  11. Wladimiroff JW, Eik-Nes SH. Amniotic fluid and placental localization. Ultrasound in Obstetrics and Gynaecology: Elsevier; 2009. p. 109-20.
  12. Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation. Am J Obstet Gynecol. 2000;182(4):909-12.
  13. Golan A, Lin G, Evron S, Arieli S, Niv D, David MP. Oligohydramnios: maternal complications and fetal outcome in 145 cases. Gynecol Obstet Invest. 1994;37(2):91-5.
  14. Desai P, Patel P, Gupta A. Decreased amniotic fluid index in low risk pregnancy: Any significance. J Obstet Gynecol Ind. 2004;54(5):464-6.
  15. Wolff F, Schaefer R. Oligohydramnios--perinatal complications and diseases in mother and child. Geburt Frauenh. 1994;54(3):139-43.
  16. Apel-Sarid L, Levy A, Holcberg G, Sheiner E. Placental pathologies associated with intra-uterine fetal growth restriction complicated with and without oligohydramnios. Arch Gynecol Obstet. 2009;280(4):549-52.
  17. Chamberlain P, Manning F, Morrison I, Harman C, Lange I. Ultrasound evaluation of amniotic fluid volume: I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 1984;150(3):245-9.
  18. Chhabra S, Dargan R, Bawaskar R. Oligohydramnios: a potential marker for serious obstetric complications. J Obstet Gynaecol. 2007;27(7):680-3.
  19. Locatelli A, Vergani P, Toso L, Verderio M, Pezzullo JC, Ghidini A. Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Arch Gynecol Obstet. 2004;269(2):130-3.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2022 Journal of Pakistan Society of Internal Medicine.